X-64917843-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_018684.4(ZC4H2):c.615T>A(p.Leu205=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,208,636 control chromosomes in the GnomAD database, including 1,907 homozygotes. There are 4,972 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.082 ( 1029 hom., 2371 hem., cov: 22)
Exomes 𝑓: 0.0087 ( 878 hom. 2601 hem. )
Consequence
ZC4H2
NM_018684.4 synonymous
NM_018684.4 synonymous
Scores
12
Clinical Significance
Conservation
PhyloP100: -0.0390
Genes affected
ZC4H2 (HGNC:24931): (zinc finger C4H2-type containing) This gene encodes a member of the zinc finger domain-containing protein family. This family member has a C-terminal zinc finger domain that is characterized by four cysteine residues and two histidine residues, and it also includes a coiled-coil region. This protein has been detected as an autoantigen in hepatocellular carcinoma patients. This gene has been identified as a potential candidate for X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004156381).
BP6
Variant X-64917843-A-T is Benign according to our data. Variant chrX-64917843-A-T is described in ClinVar as [Benign]. Clinvar id is 587843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.039 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC4H2 | NM_018684.4 | c.615T>A | p.Leu205= | synonymous_variant | 5/5 | ENST00000374839.8 | NP_061154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC4H2 | ENST00000374839.8 | c.615T>A | p.Leu205= | synonymous_variant | 5/5 | 1 | NM_018684.4 | ENSP00000363972 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0822 AC: 9117AN: 110934Hom.: 1030 Cov.: 22 AF XY: 0.0710 AC XY: 2356AN XY: 33180
GnomAD3 genomes
AF:
AC:
9117
AN:
110934
Hom.:
Cov.:
22
AF XY:
AC XY:
2356
AN XY:
33180
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0239 AC: 4339AN: 181710Hom.: 447 AF XY: 0.0154 AC XY: 1020AN XY: 66258
GnomAD3 exomes
AF:
AC:
4339
AN:
181710
Hom.:
AF XY:
AC XY:
1020
AN XY:
66258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00866 AC: 9501AN: 1097648Hom.: 878 Cov.: 30 AF XY: 0.00716 AC XY: 2601AN XY: 363028
GnomAD4 exome
AF:
AC:
9501
AN:
1097648
Hom.:
Cov.:
30
AF XY:
AC XY:
2601
AN XY:
363028
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0822 AC: 9128AN: 110988Hom.: 1029 Cov.: 22 AF XY: 0.0713 AC XY: 2371AN XY: 33244
GnomAD4 genome
AF:
AC:
9128
AN:
110988
Hom.:
Cov.:
22
AF XY:
AC XY:
2371
AN XY:
33244
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1113
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
3276
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
P;P;P;P
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at